Postmenopausal Osteoporosis Overview

Save information for later
Sign Up

Learn About Postmenopausal Osteoporosis

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Postmenopausal Osteoporosis Local Doctors?
Ea6312. Ibv Cnrs Imr 7277 Inserm U1091 Uns, 
Nice, FR 

Christian Roux practices in Nice, France. Roux and is rated as an Elite expert by MediFind in the treatment of Postmenopausal Osteoporosis. Their top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Arthritis, Vertebroplasty, and Knee Replacement.

CHU Edouard Herriot

Lyon, FR 

Roland Chapurlat practices in Lyon, France. Chapurlat and is rated as an Elite expert by MediFind in the treatment of Postmenopausal Osteoporosis. His top areas of expertise are Postmenopausal Osteoporosis, Osteoporosis, Fibrous Dysplasia, Osteitis Fibrosa, and Hip Replacement.

 
 
 
 
Learn about our expert tiers
Learn More
Herries Road, 
Sheffield, ENG, GB 

Richard Eastell practices in Sheffield, United Kingdom. Eastell and is rated as an Elite expert by MediFind in the treatment of Postmenopausal Osteoporosis. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Hyperparathyroidism, Vertebroplasty, and Parathyroidectomy.

What are the latest Postmenopausal Osteoporosis Clinical Trials?
TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease

Summary: This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-up. A total of 2650 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-blind, Parallel-group, Phase III Study to Compare the Clinical Efficacy, Safety, and Immunogenicity of Denosumab Injection 9MW0311 With Prolia® in Postmenopausal Women With Osteoporosis

Summary: This study is a multicenter, randomized, double-blinded, parallel-group Phase III clinical study to compare the clinical efficacy, safety, and immunogenicity of 9MW0311 and Prolia® in Chinese postmenopausal women with osteoporosis at high risk for fracture.